Eli Lilly and Co (NYSE:LLY) said on Monday it will acquire privately held Merida Biosciences for up

Eli Lilly's Mounjaro wins FDA approval to reduce cardiovascular risk in high-risk T2D patients, expa

Eli Lilly agrees to acquire Merida Biosciences, the developer of autoimmune drugs, marking the lates

Eli Lilly has agreed to pay up to $2.875 billion in cash for biotechnology company Merida Bioscience

At Week 52, Taltz and Zepbound maintained or further improved psoriasis or psoriatic arthritis disea

At Week 52, Taltz and Zepbound maintained or further improved psoriasis or psoriatic arthritis disea

Eli Lilly ​said on ‌Monday it ​would ​acquire privately held ⁠Merida ​Biosciences ​for up to $2.88 b

Merida's antibody-engineering platform is designed to enable precise, durable removal of disease

Merida's antibody-engineering platform is designed to enable precise, durable removal of disease-cau

AbbVie continues to expand its immunology and neuroscience portfolio through strategic acquisitions.

AtaiBeckley Investor Alert: Kahn Swick and Foti, LLC Investigates Adequacy of Price and Process in P

NEW YORK CITY and NEW ORLEANS, Aug. 28, 2026 /PRNewswire/ -- Former Attorney General of Louisiana Ch

Prefer to listen? Hear this as a ~5-minute audio briefing on The GuruFocus Brief.Stock NewsFed Chair

Eli Lilly ​said on ‌Friday the U.S. ​FDA ​has approved its ⁠diabetes drug ​Mounjaro ​to lower the ri

Mounjaro is the first and only GIP and GLP-1 receptor agonist proven to lower heart attack, stroke o

Mounjaro is the first and only GIP and GLP-1 receptor agonist proven to lower heart attack, stroke o

FDA clearance of Lilly and Roche's Alzheimer's blood test highlights a growing diagnostics market an

New Eli Lilly study reveals that Zepbound significantly lowers monthly healthcare costs for older ad

Eli Lilly (LLY) has secured another important foothold in Alzheimer's disease after the FDA approved

Eli Lilly and Co. (NYSE:LLY) shares are trading lower Wednesday, pulling back after the stock notche

Eli Lilly and Co. shares are trading lower Wednesday, pulling back from last week's record high

Nasdaq 100 falls 0.6% as traders wait on Nvidia and hot July PCE revives September rate-hike bets. E

An official report on August 25, 2026 reveals Representative Michael Rulli's recent sale of Alph

Obesity drugs like Mounjaro and Zepbound could help the drugmaker power ahead for years. Its Alzheim

VanEck's concentrated 26-stock portfolio has outpaced Fidelity's broader 334-holding fund over five

For adults over the age of 55, including patients in Medicare's GLP-1 Bridge program, these lowe

Duquesne Family Office has beefed up its healthcare holdings.

First-of-its-kind study shows sustained Zepbound use in older adults with obesity lowers costs, rein

Lilly and AbbVie bring different growth drivers, pipelines and risks to the table. See which drugmak

Eli Lilly (NYSE:LLY | LLY Price Prediction) and Novo Nordisk (NYSE:NVO) both reported Q2 2026 result

Eli Lilly (LLY), the pharmaceutical heavyweight behind Mounjaro and Zepbound, slipped to $1,245.40 M

Eli Lilly (NYSE:LLY | LLY Price Prediction) is trading at $1,255.40, and management has guided fisca

The Food and Drug Administration has cleared a new blood test from Roche and Eli Lilly designed to h

The Food and Drug Administration cleared a blood test for identifying Alzheimer's disease symptoms,

The U.S. Food and Drug Administration has cleared Roche and partner Eli Lilly's blood test to help ​

The once-daily pill was approved for patients with a body mass index of at least 30, or between 27 a

Eli Lilly (NYSE:LLY) has outperformed the market over the past 5 years by 25.41% on an annualized ba

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Amplitude Therapeutics, a biotechnology company developing trans-amplifying RNA (taRNA) medicines an

Bryn Talkington picked Horizon Kinetics, Stephanie Link chose Elanco Animal Health, and Jason Snipe

The health care sector's oversold stocks present buying opportunities for undervalued companies.

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

The OmniAb Lilly Deal offers up to $370 million in milestones as OABI raises its 2026 cash outlook a

Small caps hit fresh highs Friday as soft retail sales and weak sentiment stalled the S&P 500, w

Vinod Khosla says AI is revolutionizing drug discovery, but drug testing needs to catch up with more

Eli Lilly filed six lawsuits against U.S. entities for illegally selling unapproved retatrutide, war

Truist Securities analyst Robyn Karnauskas maintains Eli Lilly (NYSE:LLY) with a Buy and raises t

Jim Cramer praises Lockheed Martin and Ameriprise Financial, advises against Cipher Digital. Eli Lil

Amazon Pharmacy offers eligible Medicare patients weight-loss drugs for $50 monthly under a new fede

Wells Fargo analyst Mohit Bansal maintains Eli Lilly (NYSE:LLY) with a Overweight and raises the